Analystreport

Regeneron Pharmaceuticals (REGN) had its price target raised by Morgan Stanley from $769.00 to $796.00. They now have an "equal weight" rating on the stock.

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com